4.8 Article

Estrogen Receptor β Modulates Apoptosis Complexes and the Inflammasome to Drive the Pathogenesis of Endometriosis

Journal

CELL
Volume 163, Issue 4, Pages 960-974

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2015.10.034

Keywords

-

Funding

  1. US National Eunice Kennedy Shriver National Institute of Child Health and Human Development [U54HD0077495, 5K12HD050128, U54HD007495, R01 HD082786, R01 HD07857, R01 HD08188, R01 HD-042311]
  2. NIDDK [U19 DK62434]
  3. CPRIT [CPRIT RPI10471, RP120092]
  4. NCI [P30 CA123125]

Ask authors/readers for more resources

Alterations in estrogen-mediated cellular signaling play an essential role in the pathogenesis of endometriosis. In addition to higher estrogen receptor (ER) beta levels, enhanced ER beta activity was detected in endometriotic tissues, and the inhibition of enhanced ER beta activity by an ER beta-selective antagonist suppressed mouse ectopic lesion growth. Notably, gain of ER beta function stimulated the progression of endometriosis. As a mechanism to evade endogenous immune surveillance for cell survival, ER beta interacts with cellular apoptotic machinery in the cytoplasm to inhibit TNF-alpha-induced apoptosis. ER beta also interacts with components of the cytoplasmic inflammasome to increase interleukin-1 beta and thus enhance its cellular adhesion and proliferation properties. Furthermore, this gain of ER beta function enhances epithelial-mesenchymal transition signaling, thereby increasing the invasion activity of endometriotic tissues for establishment of ectopic lesions. Collectively, we reveal how endometrial tissue generated by retrograde menstruation can escape immune surveillance and develop into sustained ectopic lesions via gain of ER beta function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available